Morgan Stanley | researcs NORTH AMERICA INSIGHT 2 January 30, 2018 05:01 AM GMT Alternative Asset Managers Can Alts Unlock Value with C-Corp Conversions ° We think APO could unlock the most value by converting to a C-corp with 26% in our upside case vs. -14% in our downside c...
Results for “Morgan Stanley Healthcare Research”
Search across the indexed text of every released document.
Names that match “Morgan Stanley Healthcare Research”
1,523 documents found
Health: Not Tremendously Prescriptive Vision 2030 a start but Needs Transparent Proposals The Saudi government’s Vision 2030 document calls for an improvement in healthcare in Saudi Arabia. The private healthcare sector has some role to play; the National Transformation Plan (N...
Eye on the Market | april 9, 2012 J.P Morgan Q&A on the USA, with a watchful eye on the risk of giant man-eating plants; Spain Now that P/E multiples have risen off the bottom, what’s the outlook for P/E multiples and earnings from here? The return on the S&P this year has bee...
…11 Okt-11 Apr-12 Emerging market sovereign bonds (EMBI Global) Emerging market corporate bonds (CEMBI Broad) Source: JP Morgan, UBS, as of 15 October 2012 Note: Past performance is not an indication of future returns. 28 For further information please contact CIO's asset class sp...
60 Years of Investigative Satire: The Best of Paul Krassner Introduction by Andy Borowitz Blurb by Art Spiegelman Click on this for a High Res Photo. What They Say About the Author “Paul’s own writing, in particular, seemed daring and ad...
…ral market commentary. Opinions expressed herein are those of Michael Cembalest and may differ from those of other J.P. Morgan employees and affiliates. This information in no way constitutes J.P. Morgan research and should not be treated as such. Further, the views expressed her...
Eye on the Market | August 4, 2011 J.P Morgan Today the Delaware, with the caption “America’s structural resilience, fortitude and ingenuity will carry the economy and financial markets in 2011 —and beyond”. Our job is not to point to where we would like the financial markets t...
rules. Bank of America Merrill Lynch International Limited, Frankfurt Branch (BAMLI Frankfurt) distribu This research report has been prepared and issued by MLPF&S and/or one or more of its non-US affilia responsibility for research reports of its non-US affiliates distributed to...
Robin Solomon EXECUTIVE PROFILE In a career spanning three decades in academic medicine, Robin Solomon has combined patient care, clinical research, philanthropy and business development expertise to build strategic alliances, institutional recognition and revenue. In evolving le...
Sprout Capital Healthcare Technology Portfolios: Since 1995, members of the New Leaf team made all of the healthcare technology investments in the Sprout Funds while they were part of the investing team at the Sprout Group. The Sprout Funds were venture capital funds that were d...
Sprout Capital VIL, L.P. (Healthcare Technology Portfolio) $ amounts in millions, as of March 31, 2014 Please refer to Endnotes 1,],K,L,M and N in this Appendix. Gross Multiple Gross Vintage Total Realized Unrealize Total (Realized Multiple Company Year Cost Value d Value Valu...
Eye on the Market | July 25, 2011 J.P Morgan Topics: US debt ceiling negotiations, a more ambitious European bailout plan (finally), and how large cap growth stocks and rising corporate profits are patiently waiting for both of them to end While we’re waiting: large cap growth...
From: us.gio@jpmorgan.com To: Undisclosed recipients:;; Subject: J.P. Morgan Eye on the Market 2/27/2012: Dire Straits Sent: 2/27/2012 5:50:08 PM Attachments: 02-27-2012 - EOTM - Dire Straits.pdf Eye on the Market, February 27, 2012 [the attached PDF is much easier to read this...
Morgan Stanley | RESEARCH On average the group currently trades at 10.8x on 2018e EPS with an average effective tax rate for economic net income (the metric NORTH AMERICA INSIGHT ~~ Exhibit 4: Breakeven P/E multiple expansion of 2.1x required to offset 16% lower earnings in a...
nikolaos.panigirtzoglou@jpmorgan.com J.P. Morgan Securities plc Seamus Mac Gorain (44-20) 7134-7761 seamus.macgorain@jpmorgan.com J.P. Morgan Securities plc Matthew Lehmann (44-20) 7134-7813 matthew.m.lehmann@jpmorgan.com J.P. Morgan Securities plc Leo Evans (44-20) 7742-2...